Content area

Abstract

Following infection or vaccination, activated B cells at extrafollicular sites or within germinal centers (GCs) undergo vigorous clonal proliferation. Proliferating lymphocytes have been shown to undertake lactate dehydrogenase A (LDHA)-dependent aerobic glycolysis; however, the specific role of this metabolic pathway in a B cell transitioning from a naïve to a highly proliferative, activated state remains poorly defined. Here, we deleted LDHA in a stage-specific and cell-specific manner. We find that ablation of LDHA in a naïve B cell did not profoundly affect its ability to undergo a bacterial lipopolysaccharide-induced extrafollicular B cell response. On the other hand, LDHA-deleted naïve B cells had a severe defect in their capacities to form GCs and mount GC-dependent antibody responses. In addition, loss of LDHA in T cells severely compromised B cell-dependent immune responses. Strikingly, when LDHA was deleted in activated, as opposed to naïve, B cells, there were only minimal effects on the GC reaction and in the generation of high-affinity antibodies. These findings strongly suggest that naïve and activated B cells have distinct metabolic requirements that are further regulated by niche and cellular interactions.

Sharma et al. identify an early metabolic checkpoint dependent upon lactate dehydrogenase for newly activated B cells to enter germinal centers.

Details

Title
Distinct metabolic requirements regulate B cell activation and germinal center responses
Author
Sharma, Rahul 1 ; Smolkin, Ryan M. 2   VIAFID ORCID Logo  ; Chowdhury, Priyanka 3 ; Fernandez, Keith Conrad 3 ; Kim, Youngjun 3 ; Cols, Montserrat 1 ; Alread, William 1 ; Yen, Wei-Feng 1   VIAFID ORCID Logo  ; Hu, Wei 1   VIAFID ORCID Logo  ; Wang, Zhong-Min 2   VIAFID ORCID Logo  ; Violante, Sara 4 ; Chaligné, Ronan 5 ; Li, Ming O. 6   VIAFID ORCID Logo  ; Cross, Justin R. 4   VIAFID ORCID Logo  ; Chaudhuri, Jayanta 6   VIAFID ORCID Logo 

 Memorial Sloan Kettering Cancer Center, Immunology Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 Weill Cornell Graduate School of Medical Sciences, Immunology and Microbial Pathogenesis Program, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Memorial Sloan Kettering Cancer Center, Donald B. and Catherine C. Marron Cancer Metabolism Center, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 Memorial Sloan Kettering Cancer Center, Computational and Systems Biology Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952) 
 Memorial Sloan Kettering Cancer Center, Immunology Program, Sloan Kettering Institute, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Weill Cornell Graduate School of Medical Sciences, Immunology and Microbial Pathogenesis Program, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
Pages
1358-1369
Publication year
2023
Publication date
Aug 2023
Publisher
Nature Publishing Group
ISSN
15292908
e-ISSN
15292916
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2843247891
Copyright
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.